RIO DE JANEIRO, BRAZIL - Along with research centers from several countries, the Federal University of Minas Gerais (UFMG) has joined the study to test the efficacy of a vaccine against the HIV virus, which impairs the body's ability to fight infections. The mosaic trial will test two immunizers designed to provide protection against different strains of the virus worldwide.
Professor Jorge Andrade Pinto of the Medical School, coordinator of the Research Group on HIV/AIDS in Children, Adolescents and Pregnant Women and responsible for the trials in Minas Gerais, explained on video to UFMG the features of the vaccine . . .
To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed? Login Here